In this regard, the health technology company said it had invested more than RM10 million to increase its production capacity by hiring more than 500 new local workers in addition to the existing 700.
In a recent statement, MeDKAD CEO and Co-Founder Ezuan Yaacob said frequent testing was a critical response in a pandemic, and Salixium could help with early detection.
“With this investment and development, we can produce up to seven million self-test kits a month to ensure the people, regardless of income, have access to our products,” he added.
Launched in July this year and available at registered pharmacies and health facilities nationwide, Salixium is the first Malaysian-made product of its kind. It has been approved for sale in Malaysia by the Ministry of Health.
Test results showed the Salixium sensitivity measure was 91.23 per cent and the specification measure was 100 per cent, making it among the most accurate on the market, according to the company. — The Health
